83
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Design of multiligand inhibitors for the swine flu H1N1 neuraminidase binding site

, , , , &
Pages 47-53 | Published online: 19 Aug 2013

Figures & data

Figure 1 Overlay of H5N1 crystal structure (2hu0, yellow) and the modeled structure of H1N1 (red). The root-mean-square deviation of the two structures is 0.81 Å.

Figure 1 Overlay of H5N1 crystal structure (2hu0, yellow) and the modeled structure of H1N1 (red). The root-mean-square deviation of the two structures is 0.81 Å.

Figure 2 Picture depicting the two regions of the H1N1 neuraminidase binding site. The red region (A) is the electronegative region, where the amine-rich functional groups of ligands bind, and the large blue region (B) a large electropositive zone. The deep binding pocket (A) could host many kinds of ligands, but high affinity can be obtained only when there is a well defined functional group interaction (electrostatic and/or structural).

Figure 2 Picture depicting the two regions of the H1N1 neuraminidase binding site. The red region (A) is the electronegative region, where the amine-rich functional groups of ligands bind, and the large blue region (B) a large electropositive zone. The deep binding pocket (A) could host many kinds of ligands, but high affinity can be obtained only when there is a well defined functional group interaction (electrostatic and/or structural).

Figure 3 Model showing docked configuration of sialic acid with H1N1 neuraminidase.

Figure 3 Model showing docked configuration of sialic acid with H1N1 neuraminidase.

Figure 4 Model showing docked configuration of oseltamivir with H1N1 neuraminidase.

Figure 4 Model showing docked configuration of oseltamivir with H1N1 neuraminidase.

Table 1 Docking energies (affinity) for different chemicals with H1N1 neuraminidase

Figure 5 Chemical structure of combination ligands. Methyl salicylate-menthol-camphor (A), methyl salicylate-camphor-menthol (B), and camphor-methyl salicylate-menthol (C). The arrows show the methylene bridges artificially created to enable the possibility of docking the combination ligand with the enzyme. Note the drop in docking energy of B (−11.18 kcal/mol) when menthol and camphor position is interchanged from A (−12.68).

Figure 5 Chemical structure of combination ligands. Methyl salicylate-menthol-camphor (A), methyl salicylate-camphor-menthol (B), and camphor-methyl salicylate-menthol (C). The arrows show the methylene bridges artificially created to enable the possibility of docking the combination ligand with the enzyme. Note the drop in docking energy of B (−11.18 kcal/mol) when menthol and camphor position is interchanged from A (−12.68).

Figure 6 Docking of methyl salicylate-menthol-camphor to neuraminidase enzyme.

Figure 6 Docking of methyl salicylate-menthol-camphor to neuraminidase enzyme.

Figure 7 Docking of methyl salicylate-camphor-menthol with neuraminidase.

Figure 7 Docking of methyl salicylate-camphor-menthol with neuraminidase.